Valeant Pharmaceuticals Picks Up OraPharma for $426M
By Catherine Shaffer
Monday, June 18, 2012
Valeant Pharmaceuticals Inc. continued its specialty pharma shopping spree with an agreement to acquire oral health firm OraPharma Inc. for $312 million with up to $114 million in additional milestones.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.